Iriguchi, Shoichi
Yasui, Yutaka
Kawai, Yohei
Arima, Suguru
Kunitomo, Mihoko
Sato, Takayuki
Ueda, Tatsuki
Minagawa, Atsutaka
Mishima, Yuta http://orcid.org/0000-0003-4945-7346
Yanagawa, Nariaki
Baba, Yuji
Miyake, Yasuyuki
Nakayama, Kazuhide
Takiguchi, Maiko
Shinohara, Tokuyuki
Nakatsura, Tetsuya
Yasukawa, Masaki http://orcid.org/0000-0002-1538-433X
Kassai, Yoshiaki
Hayashi, Akira
Kaneko, Shin http://orcid.org/0000-0003-2291-4586
Funding for this research was provided by:
Ministry of Education, Culture, Sports, Science and Technology (15H04655, 15J05263)
Japan Agency for Medical Research and Development
Article History
Received: 4 November 2019
Accepted: 14 December 2020
First Online: 18 January 2021
Competing interests
: The authors declare the following financial competing interests. S.K. is a founder, shareholder, and chief scientific officer at Thyas Co., Ltd. and received research fundings from Takeda Pharmaceutical Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Sumitomo Chemical Co., Ltd., and Thyas Co., Ltd. S.A., M.K., T. Sato., Y.B., T.S., K.N., M.T., Y. Kassai, and A.H. are employees of Takeda Pharmaceutical Co. Ltd. Y.Y. is an employee of Thyas Co. Ltd. The remaining authors declare no competing financial interests. These authors and all other authors declare no other competing interests.